Designer drugs on the Internet : a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly

Ornella Corazza, Fabrizio Schifano, Magi Farre, Paolo Deluca, Zoe Davey, Colin Drummond, Marta Torrens, Zsolt Demetrovics, Lucia Di Furia, Liv Flesland, Barbara Mervo, Jacek Moskalewicz, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Cinzia Pezzolesi, Peer van der Kreeft, Norbert Scherbaum

    Research output: Contribution to journalArticlepeer-review

    59 Citations (Scopus)
    603 Downloads (Pure)


    Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon
    Original languageEnglish
    Pages (from-to)125-129
    Number of pages4
    JournalCurrent Clinical Pharmacology
    Issue number2
    Publication statusPublished - 2011


    • ABDF
    • Bromo-Dragonfly
    • FLY-compounds
    • Internet monitoring
    • phenethylamines
    • designer drugs
    • ReDNet project
    • research chemicals
    • psychoactive drugs


    Dive into the research topics of 'Designer drugs on the Internet : a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly'. Together they form a unique fingerprint.

    Cite this